Fig. 2From: Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depressionPatient disposition. *The study drug was administered to 179 patients in the quetiapine XR 300 mg group, 74 patients in the quetiapine XR 150 mg group, and 177 patients in the placebo groupBack to article page